Trading Radar 2/22: Huntsman (HUN), PG&E (PCG) Report Results
More News related to ENDP
- Endo Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
- Men with Low Testosterone See Multiple Doctors Before Being Diagnosed; Many Dissatisfied with Current Treatment Options
- Penwest Pharma (PPCO, Endo Pharma (ENDP) Grant Valeant (VRX) Exclusive License to Market Opana(r) ER in Canada, Australia and New Zealand
- Penwest and Endo Grant Valeant Pharmaceuticals Exclusive License to Market Opana(r) ER in Canada, Australia and New Zealand
- Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference
More News related to HUN
- Huntsman (HUN) Announces Settlement With Banks for $1.73 Billion of Cash and Financing
- Huntsman Reaches Settlement With Banks for $1.73 Billion of Cash and Financing
- Huntsman Acquires Baroda Division of Metrochem Industries
- Huntsman Obtains Court Order Against Kiri Dyes, India
- Huntsman Appoints New President for Performance Products Division
More News related to PCG
- PG&E Corporation (PCG) Appoints Christopher P. Johns as President
- Christopher P. Johns is Named President of Pacific Gas and Electric Company
- Oppenheimer Initiates Coverage On Several Utility Companies
- PG&E Teams With NRG Energy and eSolar for 92 Megawatts of Solar Thermal Power
- PG&E Corporation Declares Quarterly Common Stock Dividend; Utility Declares Preferred Stock Dividends
StreetInsider.com Trading Radar:
Endo Pharmaceuticals Holdings (Nasdaq: ENDP) is expected to report results before the open Friday with analysts looking for EPS of $0.44 and revenues of $285.7 million.
Huntsman (NYSE: HUN) is expected to report results before the open Friday with analysts looking for EPS of $0.25 and revenues of $2.28 billion.
PG&E (NYSE: PCG) is expected to report results before the open Friday with analysts looking for EPS of $0.55 and revenues of $3.15 billion.
For Real-Time Market Moving News Sign Up for StreetInsider.com Premium - FREE TRIAL!
Related Categories
Special ReportsStocks Mentioned
+0.07
-11.30Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
